The pandemic is showing fearsome fatality rates.
OMRF has answered the call for personal protective equipment donations and is joining the Covid-19 testing efforts.
In a new study, the OMRF compound OKN-007 is being combined with the current standard-of-care medication for glioblastoma.
OMRF VP of Clinical Affairs Judith James received a pair of distinguished honors at the American College of Rheumatology’s annual meeting.
Berkley is board certified in neurology and sees patients in OMRF’s Multiple Sclerosis Center of Excellence.
In MS, immune cells attack the protective covering of nerves in the brain, causing vision problems, tremors, paralysis, painful spasms, imbalance and cognitive changes.